Inspira Technologies (NASDAQ: IINN) is a commercial-stage medical device company specializing in advanced respiratory support and real-time blood monitoring solutions. The Company’s U.S. Food and Drug Administration-cleared INSPIRA™ ART100 system is approved for cardiopulmonary bypass in the U.S. and ECMO (Extracorporeal Membrane Oxygenation) procedures outside the U.S and serves as a foundation for the development of the INSPIRA ART500, a next-generation system designed to deliver oxygenation while patients remain awake and spontaneously breathing. Inspira Technologies is also advancing HYLA™, a proprietary blood sensor platform offering continuous, non-invasive monitoring. With multiple cleared products, a growing IP portfolio, and strategic streamlining of its operations, Inspira Technologies is increasingly positioned as an attractive platform within the life-support and MedTech landscape.
| Website | http://www.inspira-technologies.com |
| Employees | 53 (0 on RocketReach) |
| Founded | 2018 |
| Phone | +972 9-966-4488 |
| Industry | Medical Equipment Manufacturing |
| Keywords | Respiratory Support, Non Invasive Ventilation, Medical Technology, Respiratory Devices, Ventilator Technology, Innovative Devices, Inhalation Therapy, Breathing Support, Respiratory Care, Lung Health, Pulmonary Care, Medical Devices, Health Technology, Critical Care, Medical Innovation, Clinical Solutions, Oxygen Therapy, Alternative Therapies, Healthcare Technology |
Looking for a particular Inspira Technologies employee's phone or email?
Inspira Technologies Questions
Related Companies
